Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Autologous AD-MSCs for Post-Prostatectomy Urinary Incontinence
NCT04426643Phase 2Completed
- Start
- Aug 2020
- Primary completion
- Feb 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of autologous adipose-derived mesenchymal stromal cells in urinary incontinence (UI). Started Aug 2020; status: completed.
02
Drugs
autologous adipose-derived mesenchymal stromal cells
03
Conditions
urinary incontinence (UI)
Beyond the preview
Go deeper on NCT04426643.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04426643.